BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15083081)

  • 1. Nasolacrimal obstruction secondary to I(131) therapy.
    Burns JA; Morgenstern KE; Cahill KV; Foster JA; Jhiang SM; Kloos RT
    Ophthalmic Plast Reconstr Surg; 2004 Mar; 20(2):126-9. PubMed ID: 15083081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lacrimal drainage system obstruction associated to radioactive iodine therapy for thyroid carcinoma].
    Fonseca FL; Lunardelli P; Matayoshi S
    Arq Bras Oftalmol; 2012; 75(2):97-100. PubMed ID: 22760799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients.
    Morgenstern KE; Vadysirisack DD; Zhang Z; Cahill KV; Foster JA; Burns JA; Kloos RT; Jhiang SM
    Ophthalmic Plast Reconstr Surg; 2005 Sep; 21(5):337-44. PubMed ID: 16234694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between radioactive iodine therapy for thyroid carcinoma and nasolacrimal drainage system obstruction.
    Cetinkaya A; Kersten RC
    Ophthalmic Plast Reconstr Surg; 2007; 23(6):496. PubMed ID: 18030131
    [No Abstract]   [Full Text] [Related]  

  • 5. Endoscopic dacryocystorhinostomy following radioactive iodine thyroid ablation.
    Van Tassel SH; Segal KL; Hsu NM; Kacker A; Lelli GJ
    Orbit; 2017 Apr; 36(2):59-63. PubMed ID: 28388347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma.
    Kloos RT; Duvuuri V; Jhiang SM; Cahill KV; Foster JA; Burns JA
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5817-20. PubMed ID: 12466391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma.
    Shepler TR; Sherman SI; Faustina MM; Busaidy NL; Ahmadi MA; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2003 Nov; 19(6):479-81. PubMed ID: 14625496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous silicone intubation through the osteotomy and the nasolacrimal duct during dacryocystorhinostomy.
    Bartley GB
    Am J Ophthalmol; 1996 May; 121(5):586-7. PubMed ID: 8610812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary gland dysfunction and nasolacrimal duct obstruction: stenotic changes following I-131 therapy.
    Savage MW; Sobel RK; Hoffman HT; Carter KD; Finkelstein MW; Shriver EM
    Ophthalmic Plast Reconstr Surg; 2015; 31(3):e50-2. PubMed ID: 24836449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic dacryocystorhinostomy following head and neck radiation therapy.
    Sweeney AR; Davis GE; Chang SH; Jian-Amadi A
    Orbit; 2017 Feb; 36(1):30-34. PubMed ID: 28165837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopically assisted balloon dacryoplasty treatment of incomplete nasolacrimal duct obstruction.
    Couch SM; White WL
    Ophthalmology; 2004 Mar; 111(3):585-9. PubMed ID: 15019340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization of nasolacrimal drainage system after radioiodine therapy in patients with thyroid cancer.
    Sakahara H; Yamashita S; Suzuki K; Imai M; Kosugi T
    Ann Nucl Med; 2007 Nov; 21(9):525-7. PubMed ID: 18030585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of monocanalicular stenting and balloon dacryoplasty in secondary treatment of congenital nasolacrimal duct obstruction after failed primary probing.
    Goldstein SM; Goldstein JB; Katowitz JA
    Ophthalmic Plast Reconstr Surg; 2004 Sep; 20(5):352-7. PubMed ID: 15377901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balloon catheter dilation for treatment of adults with partial nasolacrimal duct obstruction: a preliminary report.
    Perry JD; Maus M; Nowinski TS; Penne RB
    Am J Ophthalmol; 1998 Dec; 126(6):811-6. PubMed ID: 9860005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcanalicular endoscopic dacryoplasty in patients with primary acquired nasolacrimal duct obstruction.
    Lee SM; Lew H
    Graefes Arch Clin Exp Ophthalmol; 2021 Jan; 259(1):173-180. PubMed ID: 32743774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial on silicone intubation in endoscopic mechanical dacryocystorhinostomy (SEND) for primary nasolacrimal duct obstruction.
    Chong KK; Lai FH; Ho M; Luk A; Wong BW; Young A
    Ophthalmology; 2013 Oct; 120(10):2139-45. PubMed ID: 23672972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic transnasal dacryocystorhinostomy and bicanalicular silicone tube intubation.
    Apaydin KC; Fisenk F; Karayalcin B; Akar Y; Saka O
    Ophthalmologica; 2004; 218(5):306-11. PubMed ID: 15334010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson syndrome with associated nasolacrimal duct obstruction treated with dacryocystorhinostomy and Crawford silicone tube insertion.
    Auran JD; Hornblass A; Gross ND
    Ophthalmic Plast Reconstr Surg; 1990; 6(1):60-3. PubMed ID: 2268602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transcanalicular Laser Dacryocystorhinostomy: One-Year-Experience in the Treatment of Acquired Nasolacrimal Duct Obstructions].
    Koch KR; Cursiefen C; Heindl LM
    Klin Monbl Augenheilkd; 2016 Feb; 233(2):182-6. PubMed ID: 26609674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topographic and anatomical features of the nasolacrimal duct obstruction due to radioiodine treatment.
    Yartsev VD; Atkova EL; Ekaterinchev MA
    Int Ophthalmol; 2023 Sep; 43(9):3385-3390. PubMed ID: 37199817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.